Your browser doesn't support javascript.
loading
Inotuzumab ozogamicin versus FLAG-Ida in the treatment of relapsed or refractory B-cell acute lymphoblastic leukemia - real-world resource use data.
Lecat, Catherine S Y; Besley, Caroline; Hough, Rachael E; Khwaja, Asim; Furness, Caroline; Marks, David I; Fielding, Adele K.
Afiliação
  • Lecat CSY; Department of Haematology, University College London Hospitals, London, UK.
  • Besley C; Bristol Haematology & Oncology Centre, University Hospitals Bristol, Bristol, UK.
  • Hough RE; Department of Haematology, University College London Hospitals, London, UK.
  • Khwaja A; UCL Cancer Institute, London, UK.
  • Furness C; Bristol Haematology & Oncology Centre, University Hospitals Bristol, Bristol, UK.
  • Marks DI; Bristol Haematology & Oncology Centre, University Hospitals Bristol, Bristol, UK.
  • Fielding AK; UCL Cancer Institute, London, UK.
Leuk Lymphoma ; 61(2): 491-493, 2020 02.
Article em En | MEDLINE | ID: mdl-31580171
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucemia-Linfoma Linfoblástico de Células Precursoras Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucemia-Linfoma Linfoblástico de Células Precursoras Idioma: En Ano de publicação: 2020 Tipo de documento: Article